Seyyedebrahimi, ShadiSadat
Khodabandehloo, Hadi
Nasli Esfahani, Ensieh
Meshkani, Reza http://orcid.org/0000-0003-1835-2883
Clinical trials referenced in this document:
Documents that mention this clinical trial
The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
https://doi.org/10.1007/s00592-017-1098-3
Funding for this research was provided by:
Tehran University of Medical Sciences and Health Services (94-01-30-28313, 1393-04-97-1879)
Article History
Received: 15 November 2017
Accepted: 29 December 2017
First Online: 22 January 2018
Change Date: 16 June 2018
Change Type: Correction
Change Details: Oxidative stress plays a pivotal role in the pathogenesis of type 2 diabetes (T2D). In vitro and animal studies have shown that resveratrol exerts an antioxidant effect, but clinical trials addressing this effect in patients with T2D are limited. The aim of this study was to determine whether resveratrol supplementation affects oxidative stress markers in a randomized, placebo-controlled, double-blind clinical trial.
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest with the contents of this article.
: The present study was approved by the Ethics Committee of Tehran University of Medical Sciences. The research was recorded in the Iranian Web site for registration of clinical trials (ExternalRef removed: IRCT2015072523336N1).
: All participants gave written informed consent prior to entering the study.